[1]
R. K. Verbeeck and F. T. Musuamba, “The revised EMA guideline for the investigation of bioequivalence for immediate release oral formulations with systemic action”,
J Pharm Pharm Sci
, vol. 15, no. 3, pp. 376–388, Jun. 2012.